Exact Mass: 808.2297602
Exact Mass Matches: 808.2297602
Found 32 metabolites which its exact mass value is equals to given mass value 808.2297602,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Epimedin B
BaohuosideV
Baohuoside V is a natural product found in Epimedium sagittatum with data available.
Epmedin B
Epimedin B is a glycoside and a member of flavonoids. Epimedin B is a natural product found in Epimedium pubescens, Epimedium grandiflorum, and other organisms with data available. Epimedin B, a component extracted from Epimedii Folium, is reported to have antiosteoporotic activity. IC50 value: Target: In vitro: In vivo: Prednisolone-induced osteoporosis model using zebrafish was used to evaluate the antiosteoporotic activity of micro amount epimedin B. The result showed that 1 μmol·L- 1epimedin B groups were significantly increased when compared with model group; Epimedin B can prevent zebrafish osteoporosis induced by prednisolone [1]. Epimedin B, a component extracted from Epimedii Folium, is reported to have antiosteoporotic activity. IC50 value: Target: In vitro: In vivo: Prednisolone-induced osteoporosis model using zebrafish was used to evaluate the antiosteoporotic activity of micro amount epimedin B. The result showed that 1 μmol·L- 1epimedin B groups were significantly increased when compared with model group; Epimedin B can prevent zebrafish osteoporosis induced by prednisolone [1].
Epmedin
Epimedin B is a glycoside and a member of flavonoids. Epimedin B is a natural product found in Epimedium pubescens, Epimedium grandiflorum, and other organisms with data available. Epimedin B, a component extracted from Epimedii Folium, is reported to have antiosteoporotic activity. IC50 value: Target: In vitro: In vivo: Prednisolone-induced osteoporosis model using zebrafish was used to evaluate the antiosteoporotic activity of micro amount epimedin B. The result showed that 1 μmol·L- 1epimedin B groups were significantly increased when compared with model group; Epimedin B can prevent zebrafish osteoporosis induced by prednisolone [1]. Epimedin B, a component extracted from Epimedii Folium, is reported to have antiosteoporotic activity. IC50 value: Target: In vitro: In vivo: Prednisolone-induced osteoporosis model using zebrafish was used to evaluate the antiosteoporotic activity of micro amount epimedin B. The result showed that 1 μmol·L- 1epimedin B groups were significantly increased when compared with model group; Epimedin B can prevent zebrafish osteoporosis induced by prednisolone [1].
6)-glucoside]
Baohuoside V
8-Prenylkaempferol-3-4)rhamnoside>-7-glucoside (Rouhuoside)|8-Prenylkaempferol-3-[glucosyl(1->4)rhamnoside]-7-glucoside (Rouhuoside)
8-isoprenyl-rhamnocitrin-3-O-3)>-O-6)>-4-O-beta-D-glucopyranoside
5,7-dihydroxyphthalide 6-O-beta-{6-O-{3'-methoxy-4'-O-beta-[6'-O-(4'-O-carboxy-3',5'-dimethoxy)phenyl]glucopyranosyl}phenyl}glucopyranoside|rhamnakoside A
8-Prenylkaempferol-4-methylether-3-4)rhamnoside>-7-glucoside|8-Prenylkaempferol-4-methylether-3-[xylosyl(1->4)rhamnoside]-7-glucoside
8-Prenylkaempferol 3-rhamnosyl-(1->3)-[apiosyl-(1->6)-glucoside]
Epimedin B1
2-(3,4-dihydroxyphenyl)ethyl (5Z)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate
Noranhydroicaritin 3-rhamnosyl-(1->3)-[apiosyl-(1->6)-glucoside]
tetrasodium,2-[[5-[1-[3-[[bis(carboxylatomethyl)amino]methyl]-4-hydroxy-2-methyl-5-propan-2-ylphenyl]-3-oxo-2-benzofuran-1-yl]-2-hydroxy-6-methyl-3-propan-2-ylphenyl]methyl-(carboxylatomethyl)amino]acetate
C38H40N2Na4O12 (808.2171920000001)
11-(Perfluorooctyl)undecyl dimorpholinophosphinate
Sodium 3-(3-carboxypropyl)-2-[3-(9-ethyl-6,8,8-trimethyl-2-phenyl-8,9-dihydropyrano[3,2-g]quinolin-1-ium-4-yl)prop-2-en-1-ylidene]-3-methyl-1-(3-sulfonatopropyl)indoline-5-sulfonate
C42H45N2NaO9S2 (808.2464040000002)
D004396 - Coloring Agents > D002232 - Carbocyanines
2-(3,4-dihydroxyphenyl)ethyl (5Z)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate
Foxy-5 (TFA)
C28H43F3N6O14S2 (808.2230654000001)
Foxy-5 TFA, a WNT5A agonist, is a mimicking peptide of WNT5A which is a non-canonical member of the Wnt family. Foxy-5 TFA triggers cytosolic free calcium signaling without affecting β-catenin activation and it impairs the migration and invasion of epithelial cancer cells. Foxy-5 TFA effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model[1][2][3].